| Literature DB >> 27136368 |
Da Jung Jung1, Hyun Ho Cho1, Kyu-Yup Lee1.
Abstract
OBJECTIVES: Previous studies examining the association between osteoporosis (OP) and hearing loss (HL) have shown conflicting results. The objective of the present study was to examine the association between hearing impairment and OP in postmenopausal women, using appropriate statistical analyses.Entities:
Keywords: Age; Bone Density; Hearing; Osteoporosis; Postmenopausal Women
Year: 2016 PMID: 27136368 PMCID: PMC5115157 DOI: 10.21053/ceo.2015.01858
Source DB: PubMed Journal: Clin Exp Otorhinolaryngol ISSN: 1976-8710 Impact factor: 3.372
Baseline characteristics of the participants according to the absence or presence of osteoporosis
| Characteristic | Total all cohort (n=1,009) | Propensity score matched cohort (n=466) | ||||
|---|---|---|---|---|---|---|
| Non-OP (n=776) | OP (n=233) | Non-OP (n=233) | OP (n=233) | |||
| Age (yr) | 58.2±5.5 | 62.0±5.4 | <0.001 | 61.8±5.4 | 62.0±5.4 | 0.752 |
| Body mass index (kg/m2) | 24.5±3.1 | 23.6±3.0 | <0.001 | 23.8±2.9 | 23.6±3.0 | 0.492 |
| Hypertension | 93 (12.0) | 33 (14.2) | 0.378 | 24 (10.3) | 33 (14.2) | 0.203 |
| Diabetes mellitus | 395 (50.9) | 127 (54.5) | 0.334 | 118 (50.6) | 127 (54.5) | 0.404 |
| Alkaline phosphatase (IU/L) | 247.3±65.8 | 263.7±80.5 | 0.005 | 262.0±67.0 | 263.7±80.5 | 0.805 |
| Intact parathyroid hormone (pg/mL) | 67.3±27.9 | 66.9±25.4 | 0.826 | 65.2±21.5 | 66.9±25.4 | 0.457 |
| Vitamin D (ng/mL) | 17.8±6.5 | 17.5±6.4 | 0.528 | 18.3±7.1 | 17.5±6.4 | 0.208 |
| High density lipoprotein cholesterol (mg/dL) | 50.0±11.2 | 49.1±10.7 | 0.297 | 50.6±11.6 | 49.1±10.7 | 0.157 |
| Triglyceride (mg/dL) | 134.1±82.0 | 126.2±72.3 | 0.185 | 129.4±78.0 | 126.2±72.3 | 0.645 |
| Alcohol intake | 0.353 | 0.999 | ||||
| Abstinence | 347 (44.7) | 112 (48.1) | 113 (48.5) | 112 (48.1) | ||
| Moderate drinking | 414 (53.4) | 116 (49.8) | 118 (50.6) | 116 (49.8) | ||
| Heavy drinking | 10 (1.3) | 1 (0.4) | 1 (0.4) | 1 (0.4) | ||
| Unknown | 5 (0.6) | 4 (1.7) | 1 (0.4) | 4 (1.7) | ||
| Smoking | 0.659 | 0.809 | ||||
| Nonsmoker | 733 (94.5) | 217 (93.1) | 222 (95.3) | 217 (93.1) | ||
| Ex-smoker | 19 (2.4%) | 8 (3.4) | 6 (2.6) | 8 (3.4) | ||
| Current smoker | 24 (3.1%) | 6 (2.6) | 5 (2.1) | 6 (2.6) | ||
| Unknown | - | 2 (0.9) | - | 2 (0.9) | ||
| BMD of FN (g/cm2) | 0.69±0.09 | 0.57±0.07 | <0.001 | 0.66±0.08 | 0.57±0.07 | <0.001 |
| BMD of LS (g/cm2) | 0.88±0.11 | 0.67±0.07 | <0.001 | 0.86±0.11 | 0.67±0.07 | <0.001 |
| T-score of FN | –1.07±0.79 | –2.20±0.67 | <0.001 | –1.33±0.72 | –2.20±0.67 | <0.001 |
| T-score of LS | –1.10±0.92 | –2.89±0.63 | <0.001 | –1.29±0.91 | –2.89±0.63 | <0.001 |
Values are presented as mean±SD or number (%). The P-values were tested using t-test for continuous variables and the Pearson chi-square test or Fisher exact test for categorical variables.
OP, osteoporosis; non-OP, without osteoporosis; BMD, bone mineral density; FN, femoral neck; LS, lumbar spine.
Fig. 1.Distribution of propensity score before and after matching. (A) Before matching OP, (B) after matching OP, (C) before matching non-OP, and (D) after matching non-OP. OP, osteoporosis; non-OP, without osteoporosis.
Hearing thresholds according to the absence or presence of osteoporosis
| Variable | Model 1 | Model 2 | Model 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-OP | OP | Non-OP | OP | Non-OP | OP | ||||
| Low-Freq | 18.1±0.4 | 20.2±0.7 | 0.014 | 18.4±0.4 | 19.1±0.8 | 0.447 | 18.4±0.4 | 18.7±0.8 | 0.724 |
| Middle-Freq | 18.7±0.4 | 21.6±0.8 | 0.001 | 19.3±0.4 | 19.7±0.8 | 0.618 | 19.3±0.4 | 19.5±0.8 | 0.761 |
| High-Freq | 30.7±0.6 | 35.7±1.0 | <0.001 | 31.5±0.5 | 33.0±1.0 | 0.167 | 31.4±0.5 | 32.8±1.0 | 0.228 |
| Average hearing threshold | 18.6±0.4 | 21.3±0.7 | 0.001 | 19.1±0.4 | 19.6±0.7 | 0.554 | 19.1±0.4 | 19.3±0.8 | 0.740 |
Values are presented as mean±SE.
Model 1 was unadjusted, model 2 was adjusted for age, and model 3 was adjusted for age, body mass index, alcohol intake, smoking, diabetes mellitus, hypertension, high density lipoprotein cholesterol level, triglyceride level, vitamin D level, and alkaline phosphatase.
OP, osteoporosis; non-OP, without osteoporosis; Freq, frequency.
Fig. 2.Comparison of hearing thresholds between groups without OP and with OP in the propensity score matched cohort. The data are expressed as mean and standard deviation values. OP, osteoporosis; non-OP, without osteoporosis; Freq, frequency; AHT, average hearing threshold.
Association of hearing thresholds with bone mineral density
| Variable | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| St β±SE | St β±SE | St β±SE | ||||
| Lumbar spine T-score | ||||||
| Total cohort | ||||||
| Low-Freq | –0.129±0.321 | <0.001 | –0.076±0.332 | 0.019 | –0.063±0.355 | 0.077 |
| Mid-Freq | –0.140±0.333 | <0.001 | –0.051±0.335 | 0.101 | –0.037±0.357 | 0.273 |
| High-Freq | –0.159±0.427 | <0.001 | –0.060±0.424 | 0.053 | –0.045±0.451 | 0.170 |
| AHT | –0.144±0.315 | <0.001 | –0.060±0.318 | 0.056 | –0.045±0.340 | 0.181 |
| PSM cohort | ||||||
| Low-Freq | –0.130±0.437 | 0.005 | –0.115±0.427 | 0.011 | –0.089±0.448 | 0.058 |
| Mid-Freq | –0.065±0.476 | 0.159 | –0.044±0.449 | 0.316 | –0.032±0.474 | 0.489 |
| High-Freq | –0.068±0.637 | 0.141 | –0.048±0.607 | 0.273 | –0.042±0.640 | 0.367 |
| AHT | –0.085±0.441 | 0.066 | –0.064±0.417 | 0.143 | –0.048±0.440 | 0.297 |
| Femoral neck T-score | ||||||
| Total cohort | ||||||
| Low-Freq | –0.127±0.408 | <0.001 | –0.065±0.430 | 0.047 | –0.053±0.456 | 0.127 |
| Mid-Freq | –0.137±0.423 | <0.001 | –0.031±0.433 | 0.330 | –0.020±0.459 | 0.546 |
| High-Freq | –0.167±0.541 | <0.001 | –0.051±0.549 | 0.109 | –0.042±0.580 | 0.203 |
| AHT | –0.141±0.400 | <0.001 | –0.041±0.411 | 0.198 | –0.030±0.437 | 0.382 |
| PSM cohort | ||||||
| Low-Freq | –0.154±0.597 | 0.001 | –0.117±0.591 | 0.010 | –0.094±1.065 | 0.274 |
| Mid-Freq | –0.094±0.650 | 0.043 | –0.039±0.623 | 0.384 | –0.032±0.650 | 0.483 |
| High-Freq | –0.080±0.871 | 0.085 | –0.029±0.842 | 0.522 | –0.026±0.878 | 0.583 |
| AHT | –0.114±0.601 | 0.014 | –0.060±0.578 | 0.173 | –0.053±0.603 | 0.252 |
Model 1 was unadjusted, model 2 was adjusted for age, and model 3 was adjusted for age, body mass index, alcohol intake, smoking, diabetes mellitus, hypertension, high density lipoprotein cholesterol level, triglyceride level, vitamin D level, and alkaline phosphatase.
St, standardized; Freq, frequency; AHT, average hearing threshold; PSM, propensity score matched.